Topic: Viral hepatitis and cirrhosis of liver.
Question:A 30 year old business executive, who is asymptomatic, has been tested positive for Hepatitis-B surface antigen. ① How would you further investigate this individual? ② What steps would you take for the management?
Reference Material-This material is informational alone and is not specifically prepared as an answer for any question. Readers may do their own research before finalising diagnoses according to the characteristics unique to each question. Readers should not proceed without cross-referencing with relevant textbooks as well as standard guidelines available.
As a 30-year-old business executive with a positive Hepatitis-B surface antigen (HBsAg) test result and no symptoms, it is essential to conduct further investigations to determine the stage of the infection and assess the risk of complications.
The following tests and assessments should be performed:
1. Hepatitis B core antibody (anti-HBc) and Hepatitis B surface antibody (anti-HBs) tests: These tests will help determine whether the individual has had a past infection or is currently infected. A positive anti-HBc result indicates exposure to the virus, while a positive anti-HBs result suggests immunity from a past infection or vaccination.
2. Hepatitis B e-antigen (HBeAg) and Hepatitis B e-antibody (anti-HBe) tests: These tests help determine the level of viral replication and infectivity. A positive HBeAg result indicates high viral replication and increased infectivity, while a positive anti-HBe result suggests lower replication and infectivity.
3. Hepatitis B viral load (HBV DNA) test: This test measures the amount of viral DNA in the blood, which reflects the level of viral replication. Higher viral loads indicate a higher risk of liver damage and disease progression.
4. Liver function tests (LFTs): These tests assess liver health by measuring enzymes and proteins in the. Abnormal LFT results may indicate liver damage or inflammation.
5.Abdominal ultrasound: To exclude any chronic liver changes like cirrhosis or tumors. Also to measure liver and spleen size.
6. Fibroscan: Non-invasive method to determine degree of liver fibrosis using transient elastography. Can avoid need for liver biopsy in some cases.
7. Liver biopsy: Required in some cases to stage the degree of fibrosis and ascertain need for treatment. Also indicated if fibrosis score discrepant with other non-invasive markers.
8. Risk factor assessment: A thorough medical history should be taken to identify any risk factors for Hepatitis B transmission, such as sexual activity, intravenous drug use, or occupational exposure.
② Management steps:
1. Education and counseling: The individual should be educated about Hepatitis B, its transmission, and potential complications. They should be counseled on how to prevent the spread of the virus, such as practicing safe sex, avoiding sharing needles or personal items like razors, and getting their close contacts vaccinated.
2. Vaccination of close contacts: Family members, sexual partners, and other close contacts should be tested for Hepatitis B and vaccinated if they are not immune.Infants born to infected mothers should receive Hepatitis B immune globulin and vaccine at birth.
3. Regular monitoring: The individual should undergo regular monitoring, including LFTs, HBV DNA tests, and imaging studies, to assess disease progression and the need for treatment.
4. Antiviral therapy: If the individual has high viral loads, abnormal LFTs, or signs of liver damage, they may be considered for antiviral therapy to suppress viral replication and reduce the risk of complications. Common antiviral medications for Hepatitis B include entecavir, tenofovir, lamivudine, and adefovir.
5. Lifestyle modifications: The individual should be advised to maintain a healthy lifestyle, including a balanced diet, regular exercise, and avoiding alcohol and hepatotoxic medications to minimize liver damage.
6. Surveillance for complications: Regular screening for liver cancer and other complications should be performed, especially in individuals with cirrhosis or a family history of liver cancer. All patients require regular follow up with viral load testing, LFTs and liver imaging to monitor for any progression of disease. Frequency is usually 6-12 monthly for stable patients but more often for those on treatment or with advanced fibrosis.
7. Referral to a specialist: If the individual has advanced liver disease or complications, they should be referred to a hepatologist or a liver transplant center for further evaluation and management.
